Trials / Completed
CompletedNCT01249846
The Efficacy and Safety of 2.5 mg Chlorhexidine Gluconate Chip (PerioChip®) in Frequent Treatment Versus Routine Treatment in Therapy of Adult Chronic Periodontitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Dexcel Pharma Technologies Ltd. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy and the safety of Chlorhexidine Gluconate Chip (PerioChip®) in frequent treatment versus routine treatment in therapy of adult chronic periodontitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PerioChip ® |
Timeline
- Start date
- 2010-12-01
- First posted
- 2010-11-30
- Last updated
- 2013-01-17
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01249846. Inclusion in this directory is not an endorsement.